Relative risk of serious adverse events after one dose of the MF59-adjuvanted or non-adjuvanted seasonal influenza vaccines in non-elderly adults.

<p>Relative risk of serious adverse events after one dose of the MF59-adjuvanted or non-adjuvanted seasonal influenza vaccines in non-elderly adults.</p>

Publication Details

Journal
Figshare
Published
2024-12-30
DOI
https://doi.org/10.1371/journal.pone.0310677.s046
Primary Topic
COVID-19 epidemiological studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Relative risk of serious adverse events after one dose of the MF59-adjuvanted or non-adjuvanted seasonal influenza vaccines in non-elderly adults.

Figshare
COVID-19 epidemiological studies
article

Relative risk of serious adverse events after one dose of the MF59-adjuvanted or non-adjuvanted seasonal influenza vaccines in non-elderly adults.

article en

Abstract

<p>Relative risk of serious adverse events after one dose of the MF59-adjuvanted or non-adjuvanted seasonal influenza vaccines in non-elderly adults.</p>

Figshare
Openalex Percentile: Top 59%
COVID-19 epidemiological studies
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Relative risk of serious adverse events after one dose of the MF59-adjuvanted or non-adjuvanted seasonal influenza vaccines in non-elderly adults. · Figshare (2024) | TGRS Research Map | TGRS